Type 2 Diabetes Mellitus Clinical Trial
Official title:
Linking Self-Management and Primary Care for Diabetes
This project is primarily a behavioral study. We employed a three-arm, patient-randomized
practical effectiveness trial to evaluate the impact of two different interactive,
multimedia self-management programs, relative to "enhanced" usual care. The two
interventions will be (a) the revised program from our present study, based on our
social-ecological theory and the 5 As self-management model, plus enhanced support (ASM+ES)
that includes practical, but extensive, ongoing support and b) largely Automated
Self-Management (ASM). These programs will be compared to a realistic "enhanced usual care"
(UC) condition that will provide health risk appraisal feedback, control for computer
interactions, and provide standardized advice on behavior change, but not the hypothesized
key intervention processes of goal-setting, barriers identification, problem-solving, or
social-environmental support. Patients will be randomized to conditions within clinic and
will participate for 1 year.
The proposed project will test the effectiveness of a practical, automated-based
intervention for primary care patients to facilitate dietary and physical activity
practices, and medication-taking. Analyses will focus on primary outcomes of (a) dietary,
physical activity, medication-taking outcomes, and (b) the UKPDS risk equation as well as
secondary quality-of-life, patient-activation, and patient care outcomes (Specific Aim #2).
Using the RE-AIM measures, we will analyze the reach, effectiveness, adoption,
implementation, and maintenance of the intervention programs (Specific Aim #3), and also
factors related to program implementation, linkage to primary care, and program success with
emphasis on cost, cost-effectiveness, and mediators and moderators of outcomes such as
social-environment support (Aim #4).
Primary hypotheses:
1. That the Automated Intervention received by Automated self-management (ASM) condition
and ASM plus enhanced support conditions (ASM+ES) will be superior to usual care on the
primary outcomes.
2. That the ASM+ES condition will be superior to the ASM alone condition on primary
outcomes at the 12-month follow-up.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
| Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
| Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
| Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
| Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
| Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
| Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
| Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
| Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
| Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
| Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
| Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
| Completed |
NCT02226003 -
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
|
Phase 3 |